2 Dow Darlings Boosting Market Health This Week

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Merck & Co. (NYSE:MRK): Current price $42.97

In March, the United States Supreme Court will hear arguments regarding a case that could easily determine the extent to which drug makers are liable for injuries caused by generic equivalents of their products, says The New York Times.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Merck announces the appointment of Roger M. Perlmutter, M.D., Ph.D., as executive vice president and president of Merck Research Laboratories, effective April 15. Perlmutter will succeed Peter S. Kim, Ph.D., who has served in the role since 2003.

MRK

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business